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Loss of mtDNA activates astrocytes and leads to
spongiotic encephalopathy
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Gabrielle Capin1, Anders Paetau3, Mugen Terzioglu1, Liliya Euro 1 & Anu Suomalainen 1,4,5
Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms
underlying the clinical variability remain poorly understood. To clarify whether different brain
cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial
DNA (mtDNA) depletion in either neurons or astrocytes of mice, by inactivating Twinkle
(TwKO), the replicative mtDNA helicase. Here we show that astrocytes, the most abundant
cerebral cell type, are chronically activated upon mtDNA loss, leading to early-onset spon-
giotic degeneration of brain parenchyma, microgliosis and secondary neurodegeneration.
Neuronal mtDNA loss does not, however, cause symptoms until 8 months of age. Findings in
astrocyte-TwKO mimic neuropathology of Alpers syndrome, infantile-onset mitochondrial
spongiotic encephalopathy caused by mtDNA maintenance defects. Our evidence indicates
that (1) astrocytes are dependent on mtDNA integrity; (2) mitochondrial metabolism con-
tributes to their activation; (3) chronic astrocyte activation has devastating consequences,
underlying spongiotic encephalopathy; and that (4) astrocytes are a potential target for
interventions.
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Primary mitochondrial dysfunction is the most commoncause of inherited metabolic disease1. The central nervoussystem manifestations of mitochondrial diseases are typi-
cally progressive, with manifestations ranging from infantile cat-
astrophic epileptic encephalopathy to ataxia-epilepsy syndrome,
leukoencephalopathy, neurodegeneration or parkinsonism1,2.
Among the most severe disorders are Leigh syndrome, a subacute
necrotizing encephalopathy, and Alpers–Huttenlocher syndrome
with spongiotic changes, laminar cortical necrosis and liver
failure3–5. These devastating, lethal disorders were both char-
acterized originally by their typical neuropathological signs, which
are the key determinant of the clinical diagnosis even today6,7.
Alpers–Huttenlocher syndrome is caused by recessive muta-
tions in mitochondrial DNA (mtDNA) maintenance proteins: the
nuclear-encoded DNA polymerase gamma or replicative helicase
Twinkle8,9. These proteins, together with the mitochondrial
transcription factor A (TFAM) form the minimal mtDNA
replisome, and are essential for faithful mtDNA replication10:
their total inactivation in mice is embryonic lethal at ~E8.511–13.
Knocking out TFAM or expressing mitochondrial-targeted
endonuclease in forebrain or dopaminergic neurons of mice
resulted in progressive loss of mtDNA, eventual death of the
targeted neurons and shortened lifespan of the animals14–16. The
direct consequence of mtDNA loss is deficiency of the 13
mtDNA-encoded subunits that together with 76 nuclear-encoded
subunits build up the multisubunit enzyme complexes of oxida-
tive phosphorylation (OXPHOS) in which the Complexes I–IV








































































































































Fig. 1 Knockout of mtDNA maintenance in astrocytes causes early-onset neurodegenerative disease. a Cre-promoters and timing of activation
(PGK= phosphoglycerate kinase, GFAP= glial fibrillary-acidic-protein, CaMKII= calcium/calmodulin-dependent protein kinase-II). Targeting construct:
Boxes= exons, triangles= LoxP sites. b MtDNA amount in constitutive Twinkle knockout (TwKO), embryonal day 7.5 (Ctr= control, Het= heterozygote;
TwKO= homozygous). c Size of Twinkle-cDNA in TwKO lines; cerebral cortex. d TwKO mouse phenotypes at the age of 6 months. TwKOastro mice: small,
paraparetic posture. TwKOneuro mice are control-like. e Body weight progression: red= TwKOastro, blue= TwKOneuro, black=Control. **p< 0.01 for the
first time-point; subsequent time-points p< 0.05. f Automated grip strength test for forelimbs (6 months of age). g Beam walk test for motor coordination
(large d= large diameter, small d= small diameter beam). h Kaplan–Meier survival curves. Red= TwKOastro, blue= TwKOneuro, black= Control. i Brains of
TwKOastro, TwKOneuro, and Control mice are similar. Scale bar is 0.5 cm. The data are presented as mean and error bars indicate standard deviation.
Statistical significance: *p< 0.05, **p< 0.01
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ATP synthase. The late manifestation of neurological symptoms
in neuronal TFAM-knockout mice and the mitochondrial endo-
nuclease over-expressor mice indicates that neurons can sustain
relatively prolonged periods of mtDNA depletion and severe RC
deficiency, questioning the role of neurons as the primary culprit
in mtDNA maintenance disorders.
Astrocytes are the most abundant cell type in the brain, pro-
viding trophic and metabolic support for neurons, pruning
synapses and synthesizing neurotransmitters17. They are meta-
bolically dynamic, and considered to be glycolytic, i.e. to have
capacity to perform non-oxygen-dependent ATP-synthesis and
survive OXPHOS deficiency in vivo18,19. The contribution of
astrocytes in mitochondrial disorders has been considered to be
secondary, forming a glial scar at the sites of neuronal damage.
However, no evidence exists of the importance of mtDNA
maintenance in astrocytes in vivo.
Here we investigate the consequences of inactivation of
Twinkle, the mtDNA replicative helicase, in astrocytes or
neurons in vivo. We show that mtDNA maintenance is critical
for both cell types, but in a different manner. Progressive loss of
Twinkle and mtDNA in neurons causes late-onset neurodegen-
eration and rapid progressive late-stage neurological deteriora-
tion. Twinkle-KO in astrocytes, however, leads to wide-spread
activation of the cell type, severe early-onset progressive neuro-
logical disease, accompanied by spongiotic encephalopathy
and inflammation. The results propose that primary astrocyte
dysfunction underlies mitochondrial spongiotic encephalopathies,
such as Alpers syndrome, caused by mtDNA maintenance
defects.
Results
Generation of constitutive and conditional Twinkle-KO mice.
To clarify whether mtDNA maintenance is similarly essential for
neurons and glia, we designed cell-type-specific conditional
knockout mice for the Twnk gene encoding mitochondrial DNA
helicase Twinkle (TwKO) (Fig. 1a). We first generated early
ubiquitous inactivation of Twinkle, using PGK-promoter, driving
cre-recombinase expression from the zygote stage20. These
homozygous full-TwKO embryos showed drastically reduced
mtDNA content already at E7.5 leading to lethality at E8.5, as
previously described12 (Fig. 1b). Then we targeted Twinkle
knockout (TwKO) to postnatal forebrain neurons (TwKOneuro;
CamKII-cre) or astrocytes (TwKOastro; mouseGFAP73.12-cre)
(Fig. 1a). From the existing transgenic cre-lines targeting astro-
cytes, we chose the mGFAP73.12 promoter since (1) it starts to
express postnatally, allowing brain to develop normally; (2)
embryonic neuronal stem cells remain unaffected; (3) the profile
of expression is well characterized and specific for astrocytes21–23,
except for some expression in a population of adult neuronal
stem cells generating a small number of neurons during adult life.
Furthermore, cre-activation affects Twinkle protein and mtDNA
amounts with a delay, the latter having a half-life in brain of
several weeks24. Reporter mice expressing GFP upon recombi-
nation, crossed with mGfap73.12, indeed did not demonstrate
GFP-expression at P2, and in adult mice showed intensive
expression in cortex, hippocampus and cerebellum (Supplemen-
tary Fig. 1), and low expression in midbrain, resembling the
pattern of expression previously reported for this promoter. The
TwKOneuro and TwKOastro lines were viable, and the cre trans-
gene segregated to Mendelian ratio (TwKOneuro 42/78 and
TwKOastro 24/41). The successful TwKO was confirmed by
Twinkle cDNA analysis (Fig. 1c).
TwKO in astrocytes causes early-onset neurological disease.
Postnatal inactivation of Twinkle in neurons versus astrocytes led
to grossly different phenotypes. TwKOastro mice were sig-
nificantly smaller in size than their control littermates already at
the age of 3 months, and showed kyphosis and progressive weight
loss (Fig. 1d, e), which was not due to reduced food intake
(Supplementary Fig. 2a). At 5–6 months of age, the mice showed
an abnormal symmetric hopping gait with compromised motor
performance and weakness of hind limbs, with low pelvic posture,
progressing to paraparesis (Fig. 1f, g). The animals had a limited
lifespan of 7–8 months of age (Fig. 1h). The TwKOneuro mice
showed no difference in body weight from littermates until
~8 months of age (Fig. 1e). They developed moderate kyphosis,
but showed no motor defects and appeared wild-type-like, until
rapid deterioration of general condition and weight loss a few
days prior to death at the age of 7–9 months (Fig. 1d–h). The





































































































































































Fig. 2 Mitochondrial consequences of Twinkle inactivation. a MtDNA amount in different ages in TwKO mice. b Western blot of OXPHOS complexes
CI–CV and quantification of signals normalized to total protein. c NAD+, NADH, NADP+, NADPH amounts and their ratios in cortex lysates. The data are
presented as mean and error bars indicate standard deviation. Statistical significance: *p< 0.05, **p< 0.01, ***p< 0.001
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TwKOneuro brains was unremarkable (Fig. 1i). No specific
pathology was found in spinal cord (Supplementary Fig. 3).
TwKOneuro, although asymptomatic at the age of 3–4 months,
did demonstrate mtDNA depletion already at this age (Fig. 2a).
TwKOastro manifested with body weight loss and brain pathology
starting from the age of 2–3 months, but showed significant
mtDNA depletion only prior to death at 8 months (Fig. 2a). To
assess consequences of the two genetic manipulations, we chose to
analyze TwKOastro mainly at 5–6 months of age, when the mice
were already in advanced neurological disease, and neuronal-KO
at 7–8 months, as only then they showed morphological findings
and manifested with symptoms, and consequences to other cell
types and brain pathology could be studied.
At terminal stage of TwKOneuro and TwKOastro, mtDNA
amount showed reduction to 25 and 50% of controls’ mean,
respectively (Fig. 2a). Consequently, in TwKOastro, mtDNA-
encoded RC enzyme complex amounts (CI, III, IV) were reduced
in the brain tissue, with also OXPHOS enzyme activities,
measured by high-resolution respirometry (Fig. 2b; Supplemen-
tary Fig. 2b). Fully nuclear-encoded CII showed normal protein
amount. TwKOneuro demonstrated a combined RC protein
deficiency, with CI and CIV affected the most (~5% and 40%
of the controls’ mean, respectively; CI contains seven mtDNA-
encoded subunits; CIII one, CIV three and CV one; Fig. 2b). The
severe CI deficiency in TwKOneuro reflects the major contribution
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Fig. 3 MtDNA loss in astrocytes causes massive astrocyte activation. a, b Astrocytes (GFAP, red) in somatosensory cortex (a) and in hippocampus,
CA1 area (b) of 7–8-month-old mice and 3–4 months as shown in inset of (a). In b, boxed area is enlarged on right. c Astrocytes (GFAP, red) immuno-co-
stained with reactive astrocyte marker (Nestin, green). Insets enlarge the boxed area. Arrows show the same cells. d Astrocytic marker Aldh1l1
immunohistochemistry, counterstaining hematoxylin. TwKOastro show intensive vacuolization. Brain graphs show sampling site. Fluorescence
figures are counterstained with DAPI (blue). Bar graphs on right hand side: corresponding quantifications of GFAP+ cells (cortex and hippocampus);
GFAP+Nestin+/GFAP+, and Aldh1l1-positive cells in somatosensory cortex. The data are presented as mean and error bars indicate standard deviation.
Statistical significance: *p< 0.05, **p< 0.01, ***p< 0.001. Scale bars: 20 μm (a), 50 μm (b–d)
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of TwKOneuro mice also the overall redox status was altered with
significantly reduced NAD/NADH ratio, contributed by CI
deficiency, as the complex is a major acceptor of reducing
equivalents from NADH. NAD is the precursor of both NADPH
and NADP, and their levels were significantly decreased (Fig. 2c).
As NAD and NADP form regulate major biosynthetic reactions
in all cells, the effects of mtDNA depletion extend beyond RC, to
the whole cellular metabolism.
Loss of mtDNA maintenance activates astrocytes. Embryonic
lethality of the full TwKO predicted progressive death of
the targeted neurons or astrocytes. Unexpectedly, however,
mtDNA depletion in astrocytes caused a remarkable increase of
GFAP-positive cells with reactive astrocyte morphology in the
targeted brain regions (Fig. 3a, b). Such morphology is typical for
disease-related reactive gliosis. Activation was progressive,
starting at 2–3 months of age (absent at the age of 1 month,
Supplementary Fig. 4b), peaking in the cortex at terminal
stage. The TwKOneuro showed only modestly increased cortical
astrogliosis at the terminal stage, with increased number of
GFAP-positive cells of stellar morphology in cortex (Fig. 3a, b).
Part of the population of reactive astrocytes in TwKOastro
also co-expressed nestin, another marker of reactive gliosis.
Nestin-positive cells are not found in the cortex of controls or
TwKOneuro (Fig. 3c). The amount of GFAP+Nestin+ double-
positive cells was progressive (<30% at the age of 3–4 months,
and > 50% at 5–6 months). We then addressed the question,
whether the remarkable number of activated astrocytes was due
to their proliferation. In all three genotypes we found rare KI67-
positive cells, marking cell division, but not co-localizing in the
nuclei of the GFAP-positive cells (Supplementary Fig. 4c). Fur-
thermore, most of the astrocytes in the mouse cortex are Aldhl1-
positive, and in TwKOastro they showed slightly swollen mor-
phology, but their number was not changed (Fig. 3d). These data
imply that the gliosis is due to astrocytes activated on site, but not
their proliferation.
To examine whether the activated astrocytes were RC deficient,
we tested in situ the mitochondrial RC enzyme activities and
mitochondrial morphology. Consistent with mtDNA depletion in
astrocytes of TwKOastro mice, we found a large number of cells
with astrocyte-like stellar morphology showing typical signs of
RC deficiency: succinate dehydrogenase-positive (SDH; CII,
nuclear-encoded) and cytochrome c oxidase-negative (COX;
CIV, partially encoded by mtDNA)25 (Fig. 4a, Supplementary
Fig. 5a). Also in TwKOneuro we found COX-negative cells of
neuronal morphology at 5–6 months of age, consistent with
neuronal mtDNA depletion (Fig. 4a, Supplementary Fig. 5a). The
activated astrocytes in TwKOastro harbored accumulations of
mitochondria, a sign of mitochondrial dysfunction, both
perinuclearly and in cell processes (Fig. 4b, Supplementary
Fig. 5b). GFAP-positive cells of controls or the reactive astrocytes
of TwKOneuro mice showed no such accumulations (Fig. 4b,






























Fig. 4 OXPHOS activity and mitochondrial structure in Twinkle KOs. a In situ histochemical activity analysis of mitochondrial respiratory chain enzymes in
cortex. Brown: Complex IV, contains mtDNA-encoded subunits. Blue: fully nuclear-encoded Complex II. Arrows: respiratory chain deficient cells with
astrocyte (TwKOastro) or neuronal (TwKOneuro) morphology. Inset in TwKOneuro: hippocampus, COX-deficient cells pointed with arrows. b Mitochondrial
Complex II (SDHA, green) immuno-co-stained with astrocytes (GFAP, red), arrows point the same cells. TwKOastro astrocytes show punctate
mitochondrial accumulations. c Ultrastructure of mitochondria (arrows and purple pseudocolor). Green= nuclei, yellow= neuronal projections. Brain graph
shows sampling site. Scale bars: 50 μm (a, b), 5 μm (c)
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Fig. 5 MtDNA loss in astrocytes or neurons challenges neuronal dendrite maintenance and causes neurodegeneration. a Immunofluorescent co-staining
(overlay) of neuronal nuclei (NeuN, green), dendrites (microtubular MAP2, red) and nucleus (DAPI, blue) in hippocampus of 7–8 months old mice. b
Neuronal fine morphology with Golgi staining in 7–8 months old mice. Arrows point gross morphological changes with dendritic degeneration in both KOs
and varicosities in TwKOastro. c Dying neurons (arrows), Fluorojade-C (FJ-C) staining. Quantification below. d Apoptotic cells (arrows);
immunohistochemical staining for cleaved caspase-3 and counterstaining with hematoxylin (parallel sections to FJ-C (c)). Quantification in somatosensory
cortex and CA1 region of hippocampus below. Inset: enlarged caspase-3-positive cell. The data are presented as mean and error bars indicate standard
deviation. Statistical significance: *p< 0.05, **p< 0.01, ***p< 0.001. Scale bars: 20 μm (a, b), 50 μm (c, d)
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cell populations developed RC deficiency as a consequence of lack
of mtDNA-encoded RC subunits. Furthermore, the mitochon-
drial accumulation in astrocytic processes, similar that has been
previously found for example in Purkinje dendrites of Twinkle-
mutant Deletor mice25, suggests dysfunctional trafficking or
impaired turnover of the organelle. Electron microscopic
examination of TwKOastro cortex revealed clusters of giant
vacuolated mitochondria in cells with astrocytic morphology
(Fig. 4c). In TwKOneuro, the neuronal mitochondria appeared
swollen, but showed no vacuolization (Fig. 4c). The findings
strongly suggest that (1) astrocyte functions are dependent on
mitochondrial metabolism; (2) astrocyte activation is a cell-
autonomous consequence of Twinkle inactivation and conse-
quent mtDNA loss; (3) astrocyte activation caused by primary
mtDNA depletion is different from secondary activation after
neuronal mtDNA depletion, further pointing the importance of
mtDNA maintenance for correct astrocyte functioning.
MtDNA loss in astrocytes causes secondary neurodegeneration.
We then asked whether chronic astrocyte activation in TwKOastro
had secondary consequences for neurons. Twinkle inactivation in
astrocytes resulted in significantly disorganized neuronal dendrite
arborization in the hippocampal stratum radiatum, but the
somata of pyramidal neurons appeared intact (Fig. 5a). To
visualize the neuronal morphology in detail, we used Golgi
staining of neurons. Indeed, dendrite complexity was dramatically
decreased in both hippocampus and cortex of TwKOastro. The few
and short dendrites carried dense varicosities (Fig. 5b), potentially
as a consequence of deficient synaptic pruning. TwKOastro sec-
ondarily challenged viability of cortical neurons close to terminal
stage (Fig. 5c, d), but the death was not occurring through
caspase-3-dependent manner. However, occasional caspase-
positive neurons/glia were present in the neuropil of TwKOastro
mice (Fig. 5d). In the hippocampal CA1 region and cortex of
TwKOneuro, Golgi-staining demonstrated short dendrites,
decreased dendrite complexity and reduced neuronal body size,
accompanied by abundant cell death, significantly more than in
TwKOastro (Fig. 5b–d). These results indicate that the early-onset
phenotype of TwKOastro mice is not explained by cell death.
Instead, the chronic activation of the astrocytes challenges their
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Fig. 6 MtDNA loss in astrocytes depletes Calbindin-positive interneurons in cortex, upper neuronal layers. Immunofluorescnece staining of mid-sagittal
sections of 7–8 months old mice, brain graph shows sampling site. a Neuronal nuclei (NeuN, green), Calbindin-positive neurons (red) and nucleus (DAPI,
blue). b Quantification of NeuN-and Calbindin-positive neurons in somatosensory cortex, cortical layers I and II are boxed. Scale bars: 20 μm. The data are
presented as mean and error bars indicate standard deviation. Statistical significance: ***p< 0.001
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changes in neuron structure and late-stage secondary
neurodegeneration.
TwKOastro affects neuron subtypes and promotes inflamma-
tion. We then asked what types of cortical neurons were
differentially affected by TwKO. The overall cellularity in
the cortex was relatively well preserved in all mice (Fig. 6a).
However, TwKOastro mice showed a nearly complete loss of
GABA-ergic calbindin-positive interneurons in the somatosen-
sory cortical layers I-II at an advanced disease stage (Fig. 6a, b). In
TwKOneuro cortex, the calbindin-positive neurons remained
relatively well preserved. As the cre-expression is prominent in
these regions in both KO models, the TwKOneuro data suggest
relative resistance of these cortical neurons to mtDNA loss,
but high sensitivity of these cells to dysfunction of their astrocytic
support.
Neuronal damage typically promotes an inflammatory
response in the form of microglial activation. IBA1-positive
microglia in both KO models adopted a rounded morphology,
typical for activated microglia, whereas the control mice
microglia had quiescent ramified morphology with elongated,
branched processes (Fig. 7a). The microglial activation in
TwKOastro appeared earlier than in TwKOneuro, despite the
moderate number of apoptotic cells in TwKOastro compared
to TwKOneuro, suggesting a link between astrocyte and
microglial activation. Starting from the age of 5–6 months, the
TwKOastro mice had wide-spread chronic microglial and astro-
cyte activation accompanied by prominent myelin disorganiza-
tion, while the number of Olig2-positive oligodendrocytes and
total MBP content were unchanged (Fig. 7b, d). The axonal
structure in the white matter of corpus callosum did not show
signs of disruption (Fig. 7c). Myelin abnormalities were not
present in TwKOneuro. These results indicate that chronic
astrocyte activation and dysfunction promote inflammation and
myelin changes.
TwKO in astrocytes results in spongiotic encephalopathy. The
most remarkable pathological consequence of astrocyte-specific
TwKO was development of spongiotic vacuolization of the brain
(Fig. 8a). The vacuoles appeared in a progressive manner, starting
from cortex at 2 months of age (not present at 1 month of age,
Supplementary Fig. 4a). At the terminal stage, we found a severe
spongiotic encephalopathy with profound vacuolization of the
cortex and to a lesser extent of hippocampus, cerebellum, and
olfactory bulb (Fig. 8b). The vacuoles are often formed close to
intact astrocytic nuclei, and activated astrocytes enwrap the
vacuoles (Fig. 8c, d). Ultrastructural analysis revealed clusters of
round and oval shaped vacuoles of varying sizes, ranging from 1
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Fig. 7 Inactivation of Twinkle in astrocytes leads to microglial activation and demyelination. Immunofluorescent staining of mid-sagittal sections from
6 months old mice, brain graph shows sampling site. a Immunofluorescent staining of microglia (IBA1, red) and nucleus (DAPI, blue) in cortex. b Myelin
content (MBP, green), oligodendrocytes (Olig2, red), and nuclei (DAPI, blue). c Pan-axonal staining of long axons in corpus callosum. d Quantification of
Olig2-positive cells and length of processes of IBA1-positive cells in cortex; western blot of MBP, and its quantification. Insets: enlarged boxed area. Scale
bars: 20 μm (a), 50 μm (b, c). The data are presented as mean and error bars indicate standard deviation. Statistical significance: *p< 0.05, ***p< 0.001
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to 15 μm (Fig. 8e). We also found vacuolization of myelinated
axons at terminal stage, indicating neuronal degeneration
(Fig. 8f). Intriguingly, these changes of TwKOastro resemble clo-
sely the spongiotic pathology in infantile mitochondrial diseases,
especially Leigh syndrome and Alpers–Huttenlocher syndrome,
the latter caused by defects of mtDNA maintenance3,6,9,26.
Figure 8g summarizes the consequences of Twinkle inactiva-
tion in the two mouse models and the progression of different
changes.
Discussion
Glial cells constitute at least half of the cells in human neo-
cortex27. They are a metabolically active and dynamic cell type,
but considered to be mainly glycolytic, compared to high oxi-
dative reliance of neurons. We report here that mtDNA main-
tenance is of absolute importance for astrocyte function, as
Twinkle loss and progressive mtDNA depletion in these cells
causes an early-onset, severe neurological disease, whereas a
similar defect in neurons results in late-manifesting rapidly pro-
gressive disease course. The manifestations of TwKOastro are
among the most severe reported in any model targeting astrocytes
in vivo28,29. Our findings are not consequences of a general
decline of mitochondrial respiratory functions, because inactiva-
tion of COX assembly factor, COX10, does not lead to severe
brain pathology19. Therefore, we claim that mtDNA helicase and
replisome activity or mtDNA amount contribute to signaling that
modulates astrocyte activity.
Surprisingly, mtDNA loss in TwKOastro induced a wide-spread
chronic activation of astrocytes, followed by severe secondary
changes in neuronal morphology and progressive spongiotic
encephalopathy, with relative sparing of neurons. The
findings closely resemble those in children with mitochondrial
encephalopathies, Alpers–Huttenlocher and Leigh syndromes.
The neuropathologic characteristics of these disorders include
spongiotic encephalopathy with astrocyte activation—often
described as glial scar—relative sparing of neurons and cortical
laminar necrosis3,6,30,31. Such pathology is also typical for adult-
onset mitochondrial spinocerebellar ataxia-neuropathy-epilepsy
syndromes caused by mtDNA maintenance defects32,33. We
propose that chronic activation and dysfunction of astrocytes, as a
consequence of mtDNA maintenance defect, is a primary
underlying cause of spongiotic mitochondrial encephalopathies of
children.
What type of dysfunction could underlie the spongiosis?
Normal astrocytes promote CNS homeostatic functions by
pruning synapses, maintaining axons, providing metabolites and
trophic factors for neurons, and phagocytosing myelin debris34.
However, during a CNS insult, activation of astrocytes may
both promote and hinder recovery: microglial activation was
reported to induce neurotoxic transformation of astrocytes, to
“A1” type astrocytes. These cells lose important homeostatic
functions, which leads to poor maintenance of synapses, neuro-
degeneration, and myelin changes34–36. The neurotoxic factor
remains still unknown. We find activated astrocytes enwrapping
pathological vacuoles, and neuronal morphology and myelin
showing major secondary changes, indicative of possible toxicity.
As increasing microgliosis in TwKOastro follows astrocyte
activation, it remains possible that the interaction of the two
cell types contributes to pathology, with devastating secondary
consequences to CNS.
Our evidence suggests that defective mtDNA maintenance
in astrocytes drives their chronic activation, which promotes
pathology of mitochondrial encephalopathy in mice.
The findings offer an alternative mechanistic explanation for
pathogenesis of the most common mitochondrial
encephalopathies in infants. Furthermore, the results emphasize
the potential importance of astrocyte dysfunction in all primary
and secondary disorders with mtDNA maintenance defects,
including dopaminergic neurons in Parkinson’s disease37. We
propose that supporting of astrocytic mitochondrial function
should be considered as an attractive target for intervention, to
combat neurodegeneration.
Methods
Generation of knockout mice and phenotype testing. All the animal experi-
ments were conducted according to relevant national and international guidelines,
and approved by the Finnish Committee of Experimental Animal Research. The
generation and validation of the loxP-mice is described elsewhere38. Cre-expressing
mouse lines: [Tg(Pgk1-cre)1Lni, Camk2a-cre, GFAP(73.12)-cre and mT/mG; The
Jackson Laboratory, Stock No: 2178050, 005359, 012886, 007576 ME, USA] were
crossed to lox-P mice. Cre-mediated excision of the floxed fragment produced a
frame-shift mutation leading to a premature stop codon. For staging, the day of
vaginal plug was counted as embryonic day 0.5 (E0.5). For PGK-cre-mice, embryos
were collected at E7.5, at the time of which all genotypes were present. The astro/
neuro-TwKO offspring were born in Mendelian ratios. The mice were regularly
followed up by inspection for activity, and weighted. Beam walk test, conducted as
previously published39. Briefly, the mice were trained to navigate the 1 m poles of
two different diameters (1 and 1.5 cm) for two constitutive days and recorded on
the third day. We also used the grip strength tester (BioSEB, USA) with each mouse
recoded three times with 5 min intervals.
Tissue collection, expression analysis. The animals were sacrificed with CO2 and
decapitated. One brain hemisphere was snap-frozen in liquid nitrogen and stored
at −80 °C, and the other was sliced and immersion fixed in 4% PFA for immu-
nohistological analysis. Cortex DNA and RNA isolation was performed using
NucleoSpin TriPrep kit (Macherey-Nagel). The deletion caused by cre-excision was
analyzed from Twinkle cDNA by PCR with the following primers sites 5′-
CGTTTTGAGGACCTGCCTCT-3′, 5′-TTGGACACCTGCAGATACCG-3′. Pri-
mers used for Twinkle quantification by quantitative PCR were following: Twinkle
5′-ACGAGCAGCTCTCCTCTGA-3′, 5′-TGCTGTCTGCAGTTCCTTGT-3′ nor-
malized to β-2 microglobulin level (primers: 5′-CATGGCTCGCTCGGTGACC-3′,
5′-AATGTGAGGCGGGTGGAACTG-3′).
Histology, immunohistochemistry, and immunofluorescence. The animals were
terminally anesthetized with Mebunat (Orion, Finland) and perfused intracardially
with 4% paraformaldehyde in PBS or sacrificed with CO2. Brains were removed,
post-fixed with 4% paraformaldehyde in PBS followed by embedding in paraffin.
All histological and immunoassays were carried out on 7–10 μm sagittal sections.
Immunohistochemical and immunofluorescence stainings were described pre-
viously40 and performed on a minimum of n = 3 of each genotype. COX/SDH
activity analysis is described elsewhere38. Images were acquired with either Zeiss
AxioImager epifluorescent microscope or Zeiss LSM 780 confocal microscope.
Primary antibodies were rabbit Calbindin (Abcam), GFAP (Millipore), ALDH1L1
(Abcam), cleaved Caspase 3 (Cell Signaling Technology), IBA1 (Wako), Olig2
(Merck Millipore), KI67 (Merck Millipore); mouse Nestin (Merck Millipore),
SDHA (CII) (Abcam), NeuN (Chemion), GAD67 (Merck Millipore); Neurofila-
ment Marker pan axonal cocktail (BioLegend); chicken MAP2 (Thermo Scientific);
rat MBP (Nordic BioSite). Golgi staining was processed using the FD Rapid Gol-
giStain Kit (FD Neuro Technologies). Fluoro-Jade C was from Millipore. Mor-
phometrical analysis of coronal 80-μm-thick sections was described in ref. 41. For
cell counting, images from mid-sagittal sections were taken from three to six mice
per genotype.
Electron microscopy. Ultrastructural analysis was performed as described else-
where42. Briefly, tissue samples were fixed in phosphate buffer with 2.5% glutar-
aldehyde, post-fixed with 1% osmium tetroxide, dehydrated through ascending
concentrations of ethanol and embedded in Epon-resin. Ultrathin sections of
60 nm were cut with Leica ultramicrotome and post stained with uranylacetate and
lead citrate. Sections were imaged on a Phillips CM12 electron microscope oper-
ated at 80 kV.
Western blot. Protein from frozen tissue was extracted in 150 mM NaCl 50 mM
Tris buffer with 1% Triton-X, pH 7.6. Proteins were separated by SDS-PAGE using
4–20% gradient gels and transferred to PVDF membranes. Blots were blocked with
5% milk in Tris-buffered saline with Tween 20 (TBST) buffer for 1 h and antibodies
were incubated at +4 °C overnight. Bio-Rad TGS stain-free technology was used for
quantification of the total protein signal. Images were acquired with ChemiDoc
Imager and quantified with ImageLab software. Original blots are shown in Sup-
plementary Fig. 6.
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NAD+, NADH, NADP+, and NADPH measurement. Pyridine nucleotide con-
centrations in tissues were measured using cycling assay similar to previous
publication43.
High-resolution respirometry. Oxygen consumption rates were measured
using a high-resolution oxygraph (OROBOROS instruments using a substrate-
uncoupler-inhibitor protocol as described elsewhere44). Specific oxygen
consumption rates are expressed as pmol/(s*mg). Briefly, half of 6 months
old cerebellum was homogenized with 6–8 strokes in a 2 ml potter-Elvehjem
in respiration buffer (0.5 mM EGTA, 3 mM MgCl2, 60 mM Lactobionic acid,
20 mM Taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM D-sucrose, 1% fat-
free BSA). Oxygen consumption rates were performed in the presence of
pyruvate-glutamate-malate and activities determined with +ADP (CI), +succinate



























































































































Fig. 8 Inactivation of Twinkle in astrocytes leads to brain vacuolization and spongiotic encephalopathy. a Cortical morphology with hematoxylin/eosin
staining from terminal stage of TwKOastro and TwKOneuro mice. Representative images of the brain mid-sagittal sections. Extensive brain vacuolization in
TwKOastro indicated with arrows. b Spongiotic encephalopathy of TwKOastro has progressive nature. Brain graphs show the affected regions with severity
of pathology demonstrated with intensity of the color shading. c Vacuoles (blue arrows) and astrocyte nuclei (black arrows) in hematoxylin/eosin staining.
d Immunohistochemistry of GFAP in TwKOastro and vacuoles enwrapped by an astrocyte (blue arrow). e Representative electron micrograph of vacuoles.
Upper arrow indicates a vacuolated mitochondrion, lower arrow indicates group of vacuoles in the brain of TwKOastro. f Representative electron micrograph
of vacuolated myelinated axon. Brain graph shows sampling site. Scale bars: 100 μm (a, b); 10 μm (c), 5 μm (d). g Time-course development of brain
pathology in TwKOastro and TwKOneuro mice
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MtDNA copy number analysis. Analysis of mtDNA amount was done by
quantitative PCR, as described elsewhere45. Briefly, level of mtDNA (primers:
5′-AGGAGCCTGTTCTATAATCGATAAA-3′, 5′-GATGGCGGTATA-
TAGGCCGAA-3′) was normalized to a nuclear-encoded single-copy gene RBM15
(primers: 5′-GGACAGTTTTCTTGGGCAAC-3′, 5′-AGTTTGGCCCTGTGAGA-
CAT -3′).
Statistical methods. For statistical significance analysis, we used unpaired Stu-
dent’s t test or one-way ANOVA followed by Bonferroni tests (P ≤ 0.05).
Data availability. Authors can confirm that all relevant data are included in the
paper and/or its Supplementary Information files.
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